DR. SAMUEL FRIEDMAN M.D. NPI 1891747069

NPI Information

  • NPI: 1891747069
  • Provider Name: DR. SAMUEL FRIEDMAN, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: GUAM MEDICAL PLAZA
    633 GOV. CARLOS CAMACHO RD. STE B5
    TAMUNING, GU
    ZIP 96913
  • Phone: (671) 647-4656

Map and Directions

Get Directions

NPI Details

DR. Samuel Friedman, M.D. is a hematology and oncology internal medicine in Tamuning, GU with 59 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Samuel Friedman, M.D. NPI is 1891747069. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

GUAM MEDICAL PLAZA
633 GOV. CARLOS CAMACHO RD. STE B5
TAMUNING, GU
ZIP 96913-194
Phone: (671) 647-4656
Fax: (671) 647-4660

The NPI 1891747069 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, tbo-filgrastim, 1 microgram (HCPCS:J1447)
  • Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, potassium chloride, per 2 meq (HCPCS:J3480)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, triptorelin pamoate, 3.75 mg (HCPCS:J3315)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Injection, furosemide, up to 20 mg (HCPCS:J1940)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Fee covid-19 vac 13 res (HCPCS:0124A)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)

The enumeration date for this NPI number is 5/16/2006 and was last updated on 4/26/2017.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyMD 00033258WASHINGTONNo
2207RH0003XInternal MedicineHematology & OncologyG20360CALIFORNIANo
3207RH0003XInternal MedicineHematology & OncologyM001476GUAMYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1A-40914MEDICARE UPIN
2H101501MEDICARE PIN
3F-0096744MEDICAIDGUAM

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.